SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-20-000043
Filing Date
2020-04-29
Accepted
2020-04-29 16:38:15
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce04292020defa14a.htm DEFA14A 19199
2 jncenotice2020001.jpg GRAPHIC 120293
3 jncenotice2020002.jpg GRAPHIC 179949
4 jncenotice2020003.jpg GRAPHIC 89013
5 jncenotice2020004.jpg GRAPHIC 27230
  Complete submission text file 0001640455-20-000043.txt   594039
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 20830947
SIC: 2836 Biological Products, (No Diagnostic Substances)